secukinumab,upadacitinib,tocilizumab
abbvie,novartis,roche,jw pharma
['upadacitinib', 'thanks', 'secukinumab']
thanks carlo salvarani for this great talk on #giantcellarteritis at #eular2023 ! continue tcz after 1 year of treatment but may reduce dose or frequency if in remission. secukinumab or jaki may be effective treatments for gca, but larger trials needed to confirm. exciting! 
Rheumatologist | Advocate | Research interests in preventive healthcare in people with inflammatory arthritis